| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8814805 | European Psychiatry | 2018 | 9 Pages |
Abstract
To our knowledge, this is the first clinical trial of tACS for the treatment of symptoms of a psychiatric condition. Further studies with larger sample sizes are needed to better understand the effect of tACS on auditory hallucinations.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Juliann M. Mellin, Sankaraleengam Alagapan, Caroline Lustenberger, Courtney E. Lugo, Morgan L. Alexander, John H. Gilmore, L. Fredrik Jarskog, Flavio Fröhlich,